(-)-demecolcine increases expression ISO RGD:1323562 6480464 Demecolcine results in increased expression of GBP1 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:1323562 6480464 epigallocatechin gallate results in decreased expression of GBP1 mRNA CTD PMID:16084531 1,2-dichloroethane decreases expression ISO RGD:1623309 6480464 ethylene dichloride results in decreased expression of GBP1 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1623309 6480464 1, 2-Dimethylhydrazine results in decreased expression of GBP1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1623309 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GBP2B mRNA CTD PMID:22206623 1,4-benzoquinone multiple interactions ISO RGD:1323562 6480464 quinone promotes the reaction [IFNG protein results in increased expression of GBP1 mRNA] CTD PMID:31248982 17beta-estradiol decreases expression ISO RGD:1323562 6480464 Estradiol results in decreased expression of GBP1 mRNA CTD PMID:16705744 17beta-estradiol increases expression ISO RGD:1323562 6480464 Estradiol results in increased expression of GBP1 mRNA CTD PMID:31614463 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GBP1 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GBP1 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1323562 6480464 Tetrachlorodibenzodioxin results in decreased expression of GBP1 mRNA CTD PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1623309 6480464 Tetrachlorodibenzodioxin affects the expression of GBP2B mRNA CTD PMID:26377647 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1623309 6480464 Tetrachlorodibenzodioxin results in increased expression of GBP2B mRNA CTD PMID:26290441 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO RGD:1323562 6480464 2 more ... CTD PMID:26705709 4,4'-sulfonyldiphenol increases expression ISO RGD:1623309 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of GBP2B mRNA CTD PMID:30951980 4-hydroxynon-2-enal decreases expression ISO RGD:1623309 6480464 4-hydroxy-2-nonenal results in decreased expression of GBP1 mRNA CTD PMID:19191707 6alpha-methylprednisolone decreases expression ISO RGD:1323562 6480464 Methylprednisolone results in decreased expression of GBP1 mRNA CTD PMID:19192274 8'-apo-beta,psi-caroten-8'-al increases expression ISO RGD:1323562 6480464 apocarotenal results in increased expression of GBP1 mRNA CTD PMID:17034753 aconitine decreases expression EXP 6480464 Aconitine results in decreased expression of GBP1 protein CTD PMID:33236894 aflatoxin B1 affects expression ISO RGD:1323562 6480464 Aflatoxin B1 affects the expression of GBP1 protein CTD PMID:20106945 all-trans-retinoic acid increases expression ISO RGD:1323562 6480464 Tretinoin results in increased expression of GBP1 mRNA CTD PMID:23830798 , PMID:33167477 antirheumatic drug decreases expression ISO RGD:1323562 6480464 Antirheumatic Agents results in decreased expression of GBP1 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1323562 6480464 aristolochic acid I results in increased expression of GBP1 mRNA, aristolochic acid I results in increased expression of GBP1 protein CTD PMID:33212167 arsane affects expression ISO RGD:1323562 6480464 Arsenic affects the expression of GBP1 mRNA CTD PMID:28793237 arsane multiple interactions ISO RGD:1323562 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GBP1 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1323562 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GBP1 mRNA CTD PMID:32525701 arsenic atom affects expression ISO RGD:1323562 6480464 Arsenic affects the expression of GBP1 mRNA CTD PMID:28793237 azathioprine decreases expression ISO RGD:1323562 6480464 Azathioprine results in decreased expression of GBP1 mRNA CTD PMID:19192274 benzo[a]pyrene increases expression ISO RGD:1623309 6480464 Benzo(a)pyrene results in increased expression of GBP1 mRNA CTD PMID:23735875 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1323562 6480464 7 more ... CTD PMID:20382639 Benzo[k]fluoranthene increases expression ISO RGD:1623309 6480464 benzo(k)fluoranthene results in increased expression of GBP1 mRNA CTD PMID:26377693 beta-carotene increases expression ISO RGD:1323562 6480464 beta Carotene results in increased expression of GBP1 mRNA CTD PMID:17034753 bis(2-chloroethyl) sulfide increases expression ISO RGD:1323562 6480464 Mustard Gas results in increased expression of GBP1 mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1623309 6480464 Diethylhexyl Phthalate results in increased expression of GBP2B mRNA CTD PMID:28085963 bisphenol A affects expression ISO RGD:1323562 6480464 bisphenol A affects the expression of GBP1 mRNA CTD PMID:20170705 bisphenol A increases expression ISO RGD:1623309 6480464 bisphenol A results in increased expression of GBP2B mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO RGD:1323562 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of GBP1 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GBP1 mRNA CTD PMID:25181051 Bisphenol B increases expression ISO RGD:1323562 6480464 bisphenol B results in increased expression of GBP1 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1623309 6480464 bisphenol F results in increased expression of GBP2B mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:1323562 6480464 bisphenol F results in increased expression of GBP1 protein CTD PMID:34186270 butan-1-ol multiple interactions ISO RGD:1323562 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GBP1 mRNA CTD PMID:29432896 calcitriol increases expression ISO RGD:1323562 6480464 Calcitriol results in increased expression of GBP1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1323562 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of GBP1 mRNA CTD PMID:21592394 carbon nanotube increases expression ISO RGD:1323562 6480464 Nanotubes, Carbon results in increased expression of GBP1 mRNA CTD PMID:29348435 chloroprene decreases expression ISO RGD:1623309 6480464 Chloroprene results in decreased expression of GBP1 mRNA CTD PMID:23125180 chromium(6+) decreases expression ISO RGD:1323562 6480464 chromium hexavalent ion results in decreased expression of GBP1 mRNA CTD PMID:30690063 cisplatin multiple interactions ISO RGD:1323562 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of GBP1 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1323562 6480464 Cisplatin results in decreased expression of GBP1 mRNA CTD PMID:27392435 cyclophosphamide increases expression ISO RGD:1623309 6480464 Cyclophosphamide results in increased expression of GBP1 mRNA CTD PMID:21621594 cyclosporin A decreases expression ISO RGD:1323562 6480464 Cyclosporine results in decreased expression of GBP1 mRNA CTD PMID:20106945 , PMID:22147139 dexamethasone decreases expression ISO RGD:1623309 6480464 Dexamethasone results in decreased expression of GBP1 mRNA CTD PMID:21621594 diclofenac decreases expression ISO RGD:1323562 6480464 Diclofenac results in decreased expression of GBP1 mRNA CTD PMID:19192274 divanadium pentaoxide affects expression ISO RGD:1323562 6480464 vanadium pentoxide affects the expression of GBP1 mRNA CTD PMID:17459161 doxorubicin decreases expression ISO RGD:1323562 6480464 Doxorubicin results in decreased expression of GBP1 mRNA CTD PMID:29803840 elemental selenium decreases expression ISO RGD:1323562 6480464 Selenium results in decreased expression of GBP1 mRNA CTD PMID:19244175 ethyl methanesulfonate increases expression ISO RGD:1323562 6480464 Ethyl Methanesulfonate results in increased expression of GBP1 mRNA CTD PMID:23649840 folic acid multiple interactions ISO RGD:1623309 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GBP2B mRNA CTD PMID:22206623 formaldehyde increases expression ISO RGD:1323562 6480464 Formaldehyde results in increased expression of GBP1 mRNA CTD PMID:20655997 , PMID:23649840 fulvestrant multiple interactions ISO RGD:1323562 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of GBP1 gene CTD PMID:31601247 genistein decreases expression ISO RGD:1323562 6480464 Genistein results in decreased expression of GBP1 mRNA CTD PMID:16705744 , PMID:20884965 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of GBP1 mRNA CTD PMID:33387578 indometacin decreases expression ISO RGD:1323562 6480464 Indomethacin results in decreased expression of GBP1 mRNA CTD PMID:16984733 isobutanol multiple interactions ISO RGD:1323562 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GBP1 mRNA CTD PMID:29432896 lipopolysaccharide increases expression ISO RGD:1623309 6480464 Lipopolysaccharides results in increased expression of GBP1 mRNA CTD PMID:21461237 lipopolysaccharide multiple interactions ISO RGD:1323562 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of GBP1 mRNA] CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1323562 6480464 Lipopolysaccharides results in increased expression of GBP1 mRNA, Lipopolysaccharides results in increased expression of GBP1 protein CTD PMID:30501627 , PMID:35811015 lucanthone decreases expression ISO RGD:1323562 6480464 Lucanthone results in decreased expression of GBP1 mRNA CTD PMID:21148553 LY294002 multiple interactions ISO RGD:1323562 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IFNG protein results in increased expression of GBP1 mRNA], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LPL protein promotes the reaction [IFNG protein results in increased expression of GBP1 mRNA]] CTD PMID:15994321 metformin decreases expression EXP 6480464 Metformin results in decreased expression of GBP1 mRNA CTD PMID:31324951 methotrexate decreases expression ISO RGD:1323562 6480464 Methotrexate results in decreased expression of GBP1 mRNA CTD PMID:19192274 methotrexate decreases expression ISO RGD:1623309 6480464 Methotrexate results in decreased expression of GBP1 mRNA CTD PMID:21621594 methylmercury chloride increases expression ISO RGD:1323562 6480464 methylmercuric chloride results in increased expression of GBP1 mRNA CTD PMID:28001369 N-acetyl-L-cysteine decreases expression ISO RGD:1323562 6480464 Acetylcysteine results in decreased expression of GBP1 mRNA CTD PMID:16084531 N-nitrosodiethylamine decreases expression ISO RGD:1323562 6480464 Diethylnitrosamine results in decreased expression of GBP1 mRNA CTD PMID:21527772 nickel atom decreases expression ISO RGD:1323562 6480464 Nickel results in decreased expression of GBP1 mRNA CTD PMID:23195993 nickel atom increases expression ISO RGD:1323562 6480464 Nickel results in increased expression of GBP1 mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride increases expression ISO RGD:1323562 6480464 nickel chloride results in increased expression of GBP1 mRNA CTD PMID:17312168 nickel sulfate increases expression ISO RGD:1623309 6480464 nickel sulfate results in increased expression of GBP1 mRNA CTD PMID:16166746 ochratoxin A multiple interactions ISO RGD:1323562 6480464 [ochratoxin A results in decreased acetylation of GBP1 promoter] which results in decreased expression of GBP1 mRNA CTD PMID:29098329 ochratoxin A decreases acetylation ISO RGD:1323562 6480464 ochratoxin A results in decreased acetylation of GBP1 promoter CTD PMID:29098329 ochratoxin A decreases expression ISO RGD:1323562 6480464 ochratoxin A results in decreased expression of GBP1 mRNA CTD PMID:29098329 ozone multiple interactions ISO RGD:1623309 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GBP2B mRNA CTD PMID:34911549 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of GBP1 mRNA CTD PMID:33387578 paraquat decreases expression ISO RGD:1323562 6480464 Paraquat results in decreased expression of GBP1 mRNA CTD PMID:35182771 phenformin increases expression EXP 6480464 Phenformin results in increased expression of GBP1 mRNA CTD PMID:31324951 piroxicam decreases expression ISO RGD:1323562 6480464 Piroxicam results in decreased expression of GBP1 mRNA CTD PMID:19192274 potassium chromate decreases expression ISO RGD:1323562 6480464 potassium chromate(VI) results in decreased expression of GBP1 mRNA CTD PMID:22714537 prednisolone decreases expression ISO RGD:1323562 6480464 Prednisolone results in decreased expression of GBP1 mRNA CTD PMID:19192274 prednisolone decreases expression ISO RGD:1623309 6480464 Prednisolone results in decreased expression of GBP1 mRNA CTD PMID:21621594 propanal increases expression ISO RGD:1323562 6480464 propionaldehyde results in increased expression of GBP1 mRNA CTD PMID:26079696 rotenone increases expression EXP 6480464 Rotenone results in increased expression of GBP1 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1323562 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of GBP1 mRNA] CTD PMID:35811015 selenium atom decreases expression ISO RGD:1323562 6480464 Selenium results in decreased expression of GBP1 mRNA CTD PMID:19244175 silicon dioxide increases expression ISO RGD:1623309 6480464 Silicon Dioxide results in increased expression of GBP2B mRNA CTD PMID:23221170 silicon dioxide increases expression ISO RGD:1323562 6480464 Silicon Dioxide results in increased expression of GBP1 mRNA CTD PMID:25351596 sodium arsenate multiple interactions ISO RGD:1323562 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GBP1 mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO RGD:1323562 6480464 sodium arsenite results in decreased expression of GBP1 mRNA CTD PMID:34032870 sodium aurothiomalate decreases expression ISO RGD:1323562 6480464 Gold Sodium Thiomalate results in decreased expression of GBP1 mRNA CTD PMID:19192274 sodium dodecyl sulfate decreases expression ISO RGD:1623309 6480464 Sodium Dodecyl Sulfate results in decreased expression of GBP1 mRNA CTD PMID:21621594 succimer multiple interactions ISO RGD:1623309 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GBP1 mRNA CTD PMID:21641980 tacrolimus hydrate decreases expression ISO RGD:1623309 6480464 Tacrolimus results in decreased expression of GBP1 mRNA CTD PMID:21621594 temozolomide increases expression ISO RGD:1323562 6480464 Temozolomide results in increased expression of GBP1 mRNA CTD PMID:31758290 testosterone multiple interactions ISO RGD:1323562 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of GBP1 mRNA CTD PMID:21592394 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GBP1 mRNA CTD PMID:32741896 testosterone increases expression ISO RGD:1323562 6480464 Testosterone results in increased expression of GBP1 mRNA CTD PMID:21592394 testosterone enanthate affects expression ISO RGD:1323562 6480464 testosterone enanthate affects the expression of GBP1 mRNA CTD PMID:17440010 tetrachloromethane decreases expression ISO RGD:1623309 6480464 Carbon Tetrachloride results in decreased expression of GBP2B mRNA CTD PMID:31919559 triadimefon decreases expression ISO RGD:1323562 6480464 triadimefon results in decreased expression of GBP1 mRNA CTD PMID:26705709 tributylstannane increases expression ISO RGD:1623309 6480464 tributyltin results in increased expression of GBP2B mRNA CTD PMID:31939706 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of GBP1 mRNA CTD PMID:33387578 trovafloxacin increases expression ISO RGD:1623309 6480464 trovafloxacin results in increased expression of GBP2B mRNA CTD PMID:35537566 urethane decreases expression ISO RGD:1323562 6480464 Urethane results in decreased expression of GBP1 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1623309 6480464 Valproic Acid affects the expression of GBP1 mRNA CTD PMID:17292431 valproic acid affects expression ISO RGD:1323562 6480464 Valproic Acid affects the expression of GBP1 mRNA CTD PMID:25979313 vincristine increases expression ISO RGD:1323562 6480464 Vincristine results in increased expression of GBP1 mRNA CTD PMID:23649840 vitamin E decreases expression ISO RGD:1323562 6480464 Vitamin E results in decreased expression of GBP1 mRNA CTD PMID:19244175 zidovudine multiple interactions ISO RGD:1323562 6480464 [Zidovudine co-treated with IFNA1 protein] results in increased expression of GBP1 mRNA CTD PMID:20370541